Press Releases
Clinical ink Appoints Andrew Kraus as Chief Technology Officer
Clinical Ink, a global life science technology company, has announced the appointment of Andrew Kraus as chief technology officer. In this role, Kraus will lead the development of the company’s expanding technology portfolio to support clinical trials. Kraus is an accomplished global healthcare executive with a...
McKesson Ventures’ Dave Schulte Named One of Healthcare’s Top 25 Investors
McKesson Ventures Managing Director Dave Schulte has been recognized by GrowthCap as one of the top 25 healthcare investors for 2023. This award acknowledges healthcare investors who have demonstrated high levels of sustained investment performance and who are recognized as leaders by portfolio company CEOs, industry...
Koneksa Announces Partnership with Beacon Biosignals for Clinical Trials in Sleep and Neurologic Disorders Using EEG Biomarkers
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon platform unlocks longitudinal, at-home EEG...
Xealth Is Honored In 25th Anniversary Digital Health Awards®
McKesson Ventures portfolio company Xealth was selected as a winner in the 25th anniversary Digital Health Awards® program. This competition recognizes the best digital health resources. “Shaping Your Digital Health Future” received a Gold Award for Connected Digital Health: Consumer Directed Digital Health Programs....
RxLightning Closes $17.5M Series A to Accelerate Growth and Remove Barriers to Essential Specialty Medications
McKesson Ventures has participated in a $17.5 million Series A round for RxLightning, a platform for streamlining access and affordability for specialty medications. This brings the total the company has raised since its inception to $20.5 million. With RxLightning, healthcare providers—from those practicing at...
Aster Insights Announces that The University of Kansas Cancer Center will join the Oncology Research Information Network (ORIEN)
Aster Insights, a provider of technology-enabled data and analytics solutions for oncology discovery, has announced that The University of Kansas Cancer Center will join its Oncology Research Information Exchange Network (ORIEN). The KU Cancer Center is the latest NCI-designated cancer center to join ORIEN, which is...
ORIEN Member Presentations at 2023 ASCO Demonstrate Unique Value of Aster Insights’ Data
Aster Insights has announced its participation as a research partner at the American Society of Clinical Oncology (ASCO) Annual Meeting June 2-6, 2023, in Chicago. An oral presentation and three posters will be presented at this year’s ASCO meeting, utilizing the lifetime patient-consented longitudinal clinicogenomic...
Private AI and Replica Analytics announce partnership to tackle data privacy
Replica Analytics, an Aetion company, is partnering with data privacy software solutions developer Private AI. The partnership is a response to an urgent need for a privacy-preserving solution in healthcare and aims to provide a comprehensive solution for healthcare’s data privacy and security challenges. Replica...
Aster Insights Names Dr. Anand Shah as Chief Executive Officer
Aster Insights has announced the appointment of Dr. Anand Shah as chief executive officer, effective immediately. He succeeds Jim Gabriele, who has stepped down from his position. Gabriele and Shah have collaborated closely on a number of strategic, operational, and business development initiatives over the past six...
Twist Bioscience and Aster Insights Partner on Launch of Next Generation Oncology Panel for Cancer Research
Twist Bioscience Corporation, a company that offers high-quality synthetic DNA using its silicon platform, along with Aster Insights, has announced the availability of the AsterExome panel, which can simultaneously enable whole exome sequencing (WES) with additional coverage for target regions known to contain 620...
Other News
‘A Startup Supporting Startups’: Inside Merck Digital Sciences Studio
Last year, McKesson Ventures joined Merck, Microsoft, the Global Health Innovation Fund, Northland Ventures, and the New Jersey Institute of Technology to create the Merck Digital Sciences Studio. The studio was inspired by the work of Geof Hannigan, a computational...
Survey results show unseen burdens for individuals with endometriosis at work and school
Evidation and Myovant Sciences conducted a survey about the lived experiences of people with endometriosis and/or uterine fibroids. The results of that survey show the magnitude of the negative impacts these conditions have on employee and student experiences and...
Digital Health Assessments May Improve Parkinson Disease Diagnosis
Results from the 12-month, multicenter, observational study, WATCH-PD, were recently published in the journal Nature. The researchers found significant associations between digital biomarkers with a wearable device and conventional clinical scoring methods used in...
Komodo Health unveils MapEnhance, a new centralized network of specialty data partners
Komodo Health has recently launched MapEnhance, a feature that leverages a network of specialty data partners connecting into the company’s platform. MapEnhance builds on Komodo’s Healthcare Map, which it characterizes as a de-identified data set on 330 million...
Inside the new world of healthcare data
In a recent episode of the PharmaPhorum podcast, Evidation co-CEO and Executive Chair of the Board Deborah Kilpatrick discussed healthcare data collection in 2023 and how it intersects with stakeholders across the ecosystem, from tech and pharma companies to research...